Asset Details
Do you wish to reserve the book?
Parallel Latent Change Modeling for Depression and Pain to Predict Relapse During Buprenorphine and Suboxone Treatment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Parallel Latent Change Modeling for Depression and Pain to Predict Relapse During Buprenorphine and Suboxone Treatment
Do you wish to request the book?
Parallel Latent Change Modeling for Depression and Pain to Predict Relapse During Buprenorphine and Suboxone Treatment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Dissertation
Parallel Latent Change Modeling for Depression and Pain to Predict Relapse During Buprenorphine and Suboxone Treatment
2019
Overview
Much of what is currently known regarding treatment for opioid use disorder has been derived from heroin users, with very few investigations into the unique processes that may be involved with individuals who primarily misuse prescription opioids. Relapse is common in treatment for opioid use disorder, making the parallel processes related to relapse during treatment critical for examination. Pain and depression often co-occur in substance use disorder treatment, including opioid substitution treatments. Advanced statistical analyses that can simultaneously model these two conditions may lead to targeted clinical interventions. The objective of this dissertation was to utilize a discrete survival analysis with a growth mixture model to test time to prescription opioid relapse, predicted by parallel growth trajectories of depression and pain, in a clinical sample of patients in buprenorphine/naloxone treatment for primary prescription opioid use disorder. The latent class analysis characterized heterogeneity among patients (n=359) in the Prescription Opioid Addiction Study, a Clinical Trials Network project collected from 2006-2009. The results from this secondary analysis suggested that a 4-class solution was the most parsimonious based on global fit indices and clinical relevance. In order of class size, the 4 classes identified were: 1) typical treatment, 2) high depression and moderate pain, 3) high pain, and 4) low treatment motivation. Odds ratios for time-to-first use indicated no statistically significant difference in relapse between the high pain and the high depression classes, but all other classes differed significantly. These results emphasize the need to monitor the influence of pain and depression during stabilization on buprenorphine and naloxone. Future work may identify appropriate interventions that can be introduced to extend time-to-first prescription opioid use among patients in this clinical population.
Publisher
ProQuest Dissertations & Theses
Subject
ISBN
9781085603140, 1085603148
We currently cannot retrieve any items related to this title. Kindly check back at a later time.